A novel fluorescent tag for labelling of some antisense oligonucleotides

Neurochemistry International

Volumn 31, Issue 3, 1997, Pages 405-412

  Dubey, K K ^a   Singh, R K ^a   Misra, K ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,6 HEXANEDIAMINE; 4 ACETYLAMINO 1,8 NAPHTHALIMIDO N CAPROIC ACID; ANTISENSE OLIGODEOXYNUCLEOTIDE; CARBONYLDIIMIDAZOLE; FLUORESCENT DYE; HEXANOIC ACID DERIVATIVE; N (4 BROMOBUTYL)PHTHALIMIDE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; FLUORESCENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR BIOLOGY; PRIORITY JOURNAL; VIRUS GENOME;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FLUORESCENT DYES; HEXANOIC ACIDS; MAGNETIC RESONANCE SPECTROSCOPY; OLIGONUCLEOTIDES, ANTISENSE; PROTONS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030813866     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00110-6     Document Type: Article

References (17)

1. Adams, C. J., Murray, J. B., Arnold, J. R. P. and Stockley, P. G. (1994) Incorporation of a fluorescent nucleotide into oligoribonucleotides. Tetrahedr. Lett. 35, 1597-1600.
2. Agrawal, S., Christodolou, C. and Gait, M. J. (1986) Efficient methods for attaching non-radioactive labels to the 5′-ends of synthetic oligonucleotides. Nucl. Acids Res. 14(15), 6227-6245.
3. Agrawal, S. (1992) Antisense oligonucleotides as antiviral agents. TIBTECH 10, 152-158.
4. Agrawal, S. (1995) Pharmacokinetics of antisense oligonucleotides. Clin. Pharmacokin. 28(1), 7-16.
5. 53 for acute myelogenous leukemia myelodus plastic syndrome: initial results of a phase-1-trial. Antisense Res. Der. 3, 383-390.
6. Cohen, J. S. (1992) Oligonucleotide therapeutics. TIBTECH 10, 87-91.
7. Crook, S. T. (1994) Antisense Res. Der. 4, 145-146.
8. Gait, M. J., Matthes, W. D., Singh, M., Sproat, B. S. and Titmas, R. C. (1994) Rapid synthesis of oligodeoxyribonucleotides VII. Solid phase synthesis of oligodeoxyribonucleotides by a continuous flow phosphotriester method on a kieselguhr-polyamide support. Nucl. Acids Res. 10(20), 6243-6253.
9. Marasco, C. J., Angelino, N. J., Paul, B. and Dolnick, B. J. (1994) A simplified synthesis of acridine and/or lipid containing oligodeoxynucleotides. Tetrahedr. Lett. 35, 3029-3032.
10. Mehrotra, J., Mishra, R. K. and Misra, K. (1994) Sequence specific chemical recognition of DNA. Nucleosides & Nucleotides 10(1-3), 609-613.
11. Morgan, G. T. and Harrison, H. A. (1930) J. Soc. Chem. Ind. Trans. 49, 4131.
12. Shinozuka, K., Seto, Y., Kawata, H. and Sawai, H. (1993) Bifunctional labeling of DNA with tris(2-aminoethyl) amine derived novel fluorescent agent. Bioorg. Med. Chem. Lett. 12(3), 2883-2886.
13. Smith, L. M., Fung, S., Hunkapiller, M. W., Hunkapiller, T. J. and Hood, L. E. (1985) The synthesis of oligonucleotides containing an aliphatic amino group at the 5′-terminus: synthesis of fluorescent DNA primers for use in DNA sequence analysis. Nucl. Acids Res. 13(7), 2399-2412.
14. Stein, C. A. and Cheng, Y. C. (1994) Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261, 1004-1012.
15. Wachter, L., Jablonski, J. and Ramachandran, K. L. (1986) A simple and efficient procedure for the synthesis of 5′-aminoalkyl oligodeoxynucleotides. Nucl. Acids Res. 14(20), 7985-7996.
16. Wickstrom, E. (1992) Strategies for administering targeted therapeutic oligodeoxynucleotides. TIBTECH 10, 281-287.
17. Yamana, K., Nunota, K., Nakano, H. and Sanger, O. (1994) A new method for introduction of a pyrene group into a terminal position of an oligonucleotide. Tetrahedr. Lett. 35(16), 2555-2628.